Search research articles
Contact Us
Filters
Showing results (51-60 of 105) with videos related to
Page
of 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2009
PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen
Ursula Elsässer-Beile, Gerald Reischl, Stefan Wiehr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
Histologic Ex Vivo Validation of the [<sup>18</sup>F]SITATE Somatostatin Receptor PET Tracer
Nils F Trautwein, Sven Mattern, Martina Hinterleitner, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 12, 2017
Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer
Simon Boeke, Daniela Thorwarth, David Mönnich, et al.
Neurobiology of Disease
|
January 24, 2009
Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics
Walter Maetzler, Inga Liepelt, Matthias Reimold, et al.
Radiation Oncology (London, England)
|
November 29, 2011
Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA)
Florian C Maier, Manfred Kneilling, Gerald Reischl, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 21, 2019
2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging-Investigation of Nucleoside Transporter Interaction, <sup>18</sup>F-Labeling and Preclinical PET Imaging
Florian C Maier, Anna Schweifer, Vijaya L Damaraju, et al.
Current Radiopharmaceuticals
|
March 16, 2017
β -[<sup>18</sup>F]Fluoro Azomycin Arabinoside (β -[<sup>18</sup>F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors
Piyush Kumar, Peter Roselt, Gerald Reischl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 10, 2019
Intention-to-Treat Analysis of <sup>68</sup>Ga-PSMA and <sup>11</sup>C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After Surgery
Johannes Schwenck, Susann-Cathrin Olthof, Christina Pfannenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2005
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside
Morand Piert, Hans-Jürgen Machulla, Maria Picchio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 16, 2021
Central Insulin Modulates Dopamine Signaling in the Human Striatum
Stephanie Kullmann, Dominik Blum, Benjamin Assad Jaghutriz, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 105) with videos related to
Sort By:
Page
of 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2009
PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen
Ursula Elsässer-Beile, Gerald Reischl, Stefan Wiehr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
Histologic Ex Vivo Validation of the [<sup>18</sup>F]SITATE Somatostatin Receptor PET Tracer
Nils F Trautwein, Sven Mattern, Martina Hinterleitner, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 12, 2017
Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer
Simon Boeke, Daniela Thorwarth, David Mönnich, et al.
Neurobiology of Disease
|
January 24, 2009
Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics
Walter Maetzler, Inga Liepelt, Matthias Reimold, et al.
Radiation Oncology (London, England)
|
November 29, 2011
Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA)
Florian C Maier, Manfred Kneilling, Gerald Reischl, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 21, 2019
2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging-Investigation of Nucleoside Transporter Interaction, <sup>18</sup>F-Labeling and Preclinical PET Imaging
Florian C Maier, Anna Schweifer, Vijaya L Damaraju, et al.
Current Radiopharmaceuticals
|
March 16, 2017
β -[<sup>18</sup>F]Fluoro Azomycin Arabinoside (β -[<sup>18</sup>F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors
Piyush Kumar, Peter Roselt, Gerald Reischl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 10, 2019
Intention-to-Treat Analysis of <sup>68</sup>Ga-PSMA and <sup>11</sup>C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After Surgery
Johannes Schwenck, Susann-Cathrin Olthof, Christina Pfannenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2005
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside
Morand Piert, Hans-Jürgen Machulla, Maria Picchio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 16, 2021
Central Insulin Modulates Dopamine Signaling in the Human Striatum
Stephanie Kullmann, Dominik Blum, Benjamin Assad Jaghutriz, et al.
Page
of 11